Physician profile
Michael Tritto
NPI 1003926122
$3,082.30
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $936 · 2020: $141 · 2021: $111 · 2022: $1,399 · 2023: $342 · 2024: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $496.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $496.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supreme Orthopedic Systems, LLC | $1,223.12 | 2022 | |
| Henry Schein, INC. | $500.00 | 2019 | |
| Nevro Corp. | $167.94 | 2023 | Senza |
| Smith+Nephew, INC. | $161.09 | 2019-2023 | Grafix Pl, Renasys Go V2 Home, Pico 7 |
| Medtronic, INC. | $147.28 | 2023-2024 | Intellis Adaptivestim, Closurefast |
| Bioventus LLC | $137.08 | 2021-2022 | |
| Arthrex, INC. | $124.90 | 2019 | |
| Kerecis Limited | $109.67 | 2019-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Musculoskeletal Transplant Foundation INC. | $78.11 | 2019 | |
| Stryker Corporation | $74.45 | 2021-2023 | Ortholoc 3di, Variax |
| Horizon Therapeutics Plc | $46.91 | 2020 | |
| Integra Lifesciences Corporation | $39.71 | 2019 | |
| Biocomposites INC | $38.45 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $34.80 | 2021-2022 | |
| Sebela Pharmaceuticals INC. | $29.81 | 2022-2023 | Naftin |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $26.78 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $24.26 | 2020 | |
| Biopro, INC. | $22.38 | 2020 | |
| Wright Medical Technology, INC. | $20.63 | 2020 | |
| Djo, LLC | $17.26 | 2019 | |
| Organogenesis INC. | $17.24 | 2019 | |
| Alfasigma USA, INC. | $14.35 | 2021 | |
| Merck Sharp & Dohme LLC | $13.58 | 2019 | |
| Paragon 28, INC. | $12.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Tritto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.